论文部分内容阅读
G-CSF is the most often used in clinical hematopoietic stem and progenitor cells (HSPC) mobilization.However, G-CSF could not efficiently mobilize enough HSPC in about 10% patients.Cdc42 activity is involved in HSPC mobilization.Herein, we explore the impact of Cdc42 inhibitor ML141 on G-CSF mediated HSPC mobilization in mice.We found that using ML141 alone only presented modest HSPC mobilization effect in mice.